Financials

News Ideas Minds Technicals

EVLO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Evelo Biosciences, Inc.

Total assets of EVLO for Q3 23 is 20.63 M USD, 0.92% less than the previous Q2 23. And total liabilities decreased by 29.29% in Q3 23 to 47.33 M USD.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—